Title: Cobalt-Induced Hyperthyroidism, Cardiomyopathy, Polycythemia, and Hypertricosis in an Infant
Authors: SABBIONI EnricoPIETRA RomanoBIANCHI C.BERTANZA C.MISTURA L.
Citation: The Journal of Trace Elements in Experimental Medicine vol. 2 p. 311-319
Publication Year: 1989
JRC N°: JRC5529
URI: http://publications.jrc.ec.europa.eu/repository/handle/JRC5529
Type: Articles in Journals
Abstract: A CASE OF A 13-MONTH OLD BABY AFFECTED BY IRON DEFICIENCY ANAEMIA AND TREATED WITH A COMMERCIAL IRON-COBALT DRUG, FERRLECIT, IS DESCRIBED. AT THE TIME OF ADMISSION TO THE HOSPITAL THE BABY SHOWED PREIMITIVE HYPOTHYROIDISM, CARDIOMEGALY AND HYPERTRICOSIS. IN SPITE OF THE ADMINISTRATION OF THE DRUG FOR 12 MONTHS IT STILL SHOWED ANAEMIA. THE INTERRUPTION OF THE DRUG AND AN IRON THERAPY NORMALISED THE HEMATOLOGICAL VALUES AND THE SERUM COBALT AS DETERMINED BY NEUTRON ACTIVATION ANALYSIS (NAA). SIGNIFICANT AMOUNTS OF COBALT WERE ALSO DETERMINED IN HAIR, NAILS AND ANOMALOUS DOWN OF THE BACK WHICH SUGGEST THAT THESE TISSUES COULD BE USED AS PROBABLE INDICATOR OF COBALT EXPOSURE AND MIGHT REPRESENT A WAY OF COBALT DETOXIFICATION. THIS CASE CONFIRMS THAT GREAT CAUTION MUST BE TAKEN WHEN COBALT IS USED AS A THERAPEUTIC AGENT FOR THE TREATMENT OF ANAEMIA.
JRC Institute:Joint Research Centre Historical Collection

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.